Advertisement
Screener

INTERLEUKIN GENETICS INC Forms 3, 4 and 5: Other

INTERLEUKIN GENETICS INC Forms 3, 4 and 5: Other

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows, 4 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2013-01-03: Reporting owner Snyder Scott A.; Form 3; Security No securities are beneficially owned.; Transaction Holding.
  • 2010-08-05: Reporting owner Ehrenberger Catherine; Form 3; Security No securities are beneficially owned.; Transaction Holding.
  • 2010-04-30: Reporting owner Mills William C. III; Form 3; Security No securities are beneficially owned.; Transaction Holding.
  • 2007-07-12: Reporting owner WEAVER JAMES M; Form 3; Security No Securities owned.; Transaction Holding.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2013-01-03
holding as of filing
Snyder Scott A.
Officer (Chief Marketing Officer)
3No securities are beneficially owned.
Non-derivative · Direct
Holding
0 owned after
no price filed2013-01-03
2010-08-05
holding as of filing
Ehrenberger Catherine
Director
3No securities are beneficially owned.
Non-derivative · Direct
Holding
0 owned after
no price filed2010-08-05
2010-04-30
holding as of filing
Mills William C. III
Director
3No securities are beneficially owned.
Non-derivative · Direct
Holding
0 owned after
no price filed2010-04-30
2007-07-12
holding as of filing
WEAVER JAMES M
Director
3No Securities owned.
Non-derivative · Direct
Holding
0 owned after
no price filed2007-07-12